The controversial medical innovations bill has gained cross-party support from MPs, but charity and industry representatives say it will still have an adverse effect on patients and research.
The Access to Medical Treatments (Innovation) bill, which received its third reading in the House of Commons on Friday 29 January, would create a database of innovative medical treatments to allow doctors to prescribe experimental treatments if there is a potential benefit to terminally ill patients.
At the reading, a series of amendments to the bill, which was tabled by Conservative MP for Daventry Chris Heaton-Harris, were approved. The amendments see the clinical negligence clause, which was criticised by medical research funders and charities for adding new levels of complexity to existing laws on medical negligence, removed.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.